A press release today highlighting a new drug, based on Arazine, that is claimed to help both the redness and papules and pustules of rosacea through its ability to down regulate G-protein coupled receptor (GPCR) signaling. The company developing DMT 210, Dermata, is releasing results from their phase 1 trials, and are looking to commence phase 2 trials […]
This paper details a rosacea sufferer who suffered from rosacea lesions on his scalp, and was successfully treated with 8 weeks of Oracea and twice daily probiotics. The rosacea extended to a lesser extent to his cheeks and nose, and he also suffered from blepharitis and conjuctivitis. The patient ceased Oracea, but continuted with […]
A really insightful article in The Atlanta Journal Constitution highlights how we might be fooled by what we find on the internet. Researchers examined 65 sunscreen products that were reviewed positively on amazon.com for their performance as a sunscreen. The performance of a sunscreen is something we can measure. The AAD has minimum requirements that […]
Sales figures for rosacea prescription products are generally hard to come by. This is about as public as they get – the owners of Galderma, Nestle are touting how well Soolantra sales growth is contributing to their profits. Nestlé (NSRGY) Q2 2016 Results – Earnings Call Transcript In Nestlé skin health, we have a consumer […]
Cutis has a recent article that seeks to address a common condition amoungst acne and rosacea sufferers – visibly enlarged facial pores. This condition can have a negative effect on rosacea sufferers’ quality of life, and traditionally is hard to treat. Enlarged Facial Pores: An Update on Treatments Cutis. 2016 July;98(1):33-36. Joanna Dong, BA; Julien Lanoue, […]
